Global Markets for Drug-Device Combinations

Report Code: PHM045C

Publish Date: Jan 2013

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The market for global drug device combination products was valued at $18.5 billion in 2011 and should reach $19 billion in 2012. Total market value is expected to reach $30.5 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 9.9%.

Report Includes

  • An overview of the global market for drug-device combinations
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017
  • Detailed coverage of such product categories as drug-eluting stents (DES), drug-eluting beads (DEB), antimicrobial catheters, antibiotic-loaded bone cements, glass ionomer cements, bone graft substitutes, antibacterial-releasing dental-restorative materials, biologic wound-care products such as collagen-based dressings as therapeutic agents for wound-healing, drug-device combination products for ocular applications, and photodynamic therapy
  • Identification of current and future technologies, products, market segments/end markets, and government and regulatory agencies
  • Discussion of participating companies in light of technological strengths and weaknesses, relative market shares, marketing strengths, and innovative marketing practices
  • Detailed patent analysis and research and development updates
  • Comprehensive company profiles of major players.

SCOPE AND FORMAT

In preparing this report, an overall study of the drug-device combination market was undertaken.

The report covers the following product categories:

  • Drug-eluting stents (DES).
  • Drug-eluting beads (DEB).
  • Transdermal patches.
  • Antimicrobial catheters.
  • Antibiotic-loaded bone cements.
  • Glass ionomer cements.
  • Bone graft substitutes.
  • Antibacterial-releasing dental restorative materials.
  • Biologic wound care products, such as collagen-based dressings as therapeutic agents for wound healing.
  • Drug-device combination products for ocular applications.
  • Photodynamic therapy.
  • Many nanotechnology applications.

Devices that do not combine a drug with the delivery mechanism are not covered; for example, insulin pumps are not covered.

Related areas, such as drug delivery systems and nanotechnology, were key to the analysis as well, as these newer areas such as nanotechnology foreshadow likely product developments in the years ahead.  All major aspects of the drug-device combination market are addressed including identification of current and future technologies, products, market segments/end markets, and government and regulatory involvement.  Participating companies are discussed in light of technological strengths and weakness, relative market share, marketing strengths, and innovative marketing practices.  Included is a detailed discussion of the current regulatory environment for drug-device combination products and how it is affecting development and approval of such products.

ANALYST CREDENTIALS

Research analyst Kevin Gainer holds both B.A. and M.A. degrees in quantitative economic analysis and forecasting, and has 26 years of economic forecasting, industry intelligence and market research experience.  He is the author of six published books and more than 100 magazine articles, technical papers, analyses, and studies published in conference proceedings, including many unpublished within corporations.  He has worked as a Research Editor and Project Analyst at BCC Research since 1985, and has authored numerous BCC technology market research reports.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Drug-Device Combinations252Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY4Free
Chapter- 3: CURRENT STATUS OF THE DRUG DEVICE COMBINATION INDUSTRY9Free
Chapter- 4: REGULATORY PROCESS AND ISSUES6Free
Chapter- 5: NANOTECH COMBINATION PRODUCTS17Free
Chapter- 6: DRUG-ELUTING CORONARY STENTS14Free
Chapter- 7: PHOTODYNAMIC THERAPIES12Free
Chapter- 8: ANTIMICROBIALS AND OTHER MEDICAL DEVICE COATINGS7Free
Chapter- 9: ANTIMICROBIAL CATHETERS10Free
Chapter- 10: DRUG-ELUTING BEADS12Free
Chapter- 11: BONE CEMENTS INCLUDING ANTIBIOTIC6Free
Chapter- 12: BONE GRAFT SUBSTITUTES32Free
Chapter- 13: WOUND CARE PRODUCTS INCLUDING BIOLOGICAL DRESSINGS 15Free
Chapter- 14: DRUG-DEVICE COMBINATION PRODUCTS FOR OCCULAR APPLICATIONS7Free
Chapter- 15: IMPLANTABLES AS DRUG-DEVICE COMBINATIONS5Free
Chapter- 16: RELATED DRUG-DEVICE COMBINATIONS OF RELEVANCE12Free
Chapter- 17: PATENT ANALYSIS30Free
Chapter- 18: INDUSTRY STRUCTURE AND COMPANY PROFILES44Free
Chapter- 19: APPENDIX 1: RECENT FDA APPROVALS OF DEVICES, INCLUDING COMBINATION PRODUCTS5Free
Chapter- 20: APPENDIX 2: GLOSSARY OF RELEVANT TERMINOLOGY1Free
Published - Jan-2010| Analyst - Kevin Gainer| Code - PHM045B

Report Highlights

  • Overall sales of drug device combination products were $12 billion in 2008 and $13.7 billion in 2009. This is projected to reach  $27 billion in 2014 at a compound annual growth rate (CAGR) of 14.5%
  • Sales in coronary stents Products were nearly $4.4 billion in 2008 and $4.8 billion in 2009. This market is projected to reach $7.4 billion in 2014, for a 5-year CAGR of 9%.
  • Photodynamic therapies market was $1.3 billion in 2008, which increased slightly in 2009 to $1.5 billion. This market is projected to reach approx $2.6 billion in 2014, for a 5-year CAGR of 11.6%.
Published - Jun-2005| Analyst - Lynn Gray| Code - PHM045A

Report Highlights

  • The total market for drug-device combinations worldwide was valued at $5.4 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 13.6% to $11.5 billion in 2010.
  • The star category is drug-eluting stents that will continue to show average annual growth of 11.5%. This will result in the market doubling to $8 billion in 2010.
  • With the exception of bone graft substitutes and antibiotic bone cements, all categories will show double-digit growth.
  • The U.S. dominates the market for drug-device combination products, mainly because the largest-selling drug-eluting stents have been enthusiastically accepted in this market and consequently are penetrating the market more quickly than in Europe.

Related Reports

Global Markets for Stem Cells

Published - Jul 2012 | Publisher - Paul Evers | Code - BIO035D

The global market for stem cell products was $3.8 billion in 2011. This market is expected to reach nearly $4.3 billion in 2012 and $6.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 11.7% from 2011 to 2016.

Medical Device Coatings

Published - May 2012 | Publisher - Jim Wilson | Code - HLC049C

The global medical device coating market reached $4.8 billion in 2010 and $5.4 billion in 2011. The market is expected to grow from $5.7 billion in 2012 to nearly $8 billion in 2017, a five-year compound annual growth rate (CAGR) of 6.7%.

Biosimilars: Global Markets

Published - May 2012 | Publisher - Syamala Ariyanchira | Code - BIO090A

The global market for biosimilars reached $1.7 billion in 2010 and $2.5 billion in 2011. The market is expected to reach $3.6 billion by 2016, a compound annual growth rate (CAGR) of 7.7%.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Apr 2012 | Publisher - Shalini Shahani Dewan | Code - BIO014G

The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets for Drug-Device Combinations
Customize Report